コンドロイチン硫酸市場規模、シェア、成長分析：供給源別、形態別、用途別、地域別 - 産業予測 2025年～2032年

コンドロイチン硫酸市場規模は2023年に12億3,000万米ドルと評価され、2024年の12億8,000万米ドルから2032年には17億4,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは3.9％で成長する見通しです。

コンドロイチン硫酸の需要は、主に栄養補助食品の人気の高まりと変形性関節症の有病率の上昇によって急増しています。医薬品グレードのコンドロイチン硫酸は、尿路結石、白内障、変形性関節症などの治療に主に使用されるため、その需要は拡大するとみられます。グルクロン酸とN-アセチルガラクトサミンを豊富に含むこの化合物は、関節のパフォーマンスを高め、獣医学や眼科医療にも応用されています。食肉消費量の増加とペット産業の急成長は、動物の部位がコンドロイチン硫酸の生産に不可欠であることから、市場の成長をさらに後押しします。変形性関節症は、特に新興国において高齢者の間で一般的な病気であり、コンドロイチン硫酸が炎症を緩和し、運動能力を向上させることから、この分野の堅調な見通しが示され、大きな市場機会をもたらしています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ
• 技術分析
• 特許分析

コンドロイチン硫酸市場規模：供給源別& CAGR（2025-2032）

• 市場概要
• 牛
• 豚
• 家禽
• サメ
• その他

コンドロイチン硫酸市場規模：形態別& CAGR（2025-2032）

• 市場概要
• 粉末
• 錠剤
• その他

コンドロイチン硫酸市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 医薬品および栄養補助食品
• 動物飼料
• パーソナルケアと化粧品
• その他

コンドロイチン硫酸市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• TSI Group Co., LTD（China）
• Qingdao Wan Toulmin Biological Sources Co., Ltd.（China）
• Hebei Sanxin Industry Group Co., Ltd.（China）
• Bioiberica S.A.U.（Spain）
• Sigma-Aldrich, Inc.（Merck KGaA, Germany）
• ZPD A/S（Denmark）
• Sino Siam Biotechnique Company Ltd.（Thailand）
• BRF S.A.（Brazil）
• Bio-gen Extracts Pvt. Ltd.（India）
• Seikagaku Corporation（Japan）
• Yantai Dongcheng Pharmaceutical Group Co., Ltd.（China）
• Shandong Haiyu Biological Co., Ltd.（China）
• Jiaxing Hengjie Biopharmaceutical Co., Ltd.（China）
• Lianyungang Zhonghai Biological Technology Co., Ltd.（China）
• Yantai Ruikangda Biochemical Products Co., Ltd.（China）
• Shandong Topscience Biotech Co., Ltd.（China）
• Titan Biotech Ltd.（India）
• Fido Pharma Pvt. Ltd.（India）
• Velnex Medicare（India）
• TSI Group Ltd.（United States）

結論と推奨事項

Chondroitin Sulfate Market size was valued at USD 1.23 billion in 2023 and is poised to grow from USD 1.28 billion in 2024 to USD 1.74 billion by 2032, growing at a CAGR of 3.9% during the forecast period (2025-2032).

The demand for chondroitin sulfate is surging, primarily driven by the increasing popularity of nutraceutical products and the rising prevalence of osteoarthritis. As pharmaceutical-grade chondroitin sulfate is predominantly used for treating conditions like UTI, cataracts, and osteoarthritis, its demand is set to expand. This compound, rich in glucuronic acid and N-acetylgalactosamine, enhances joint performance and has applications in veterinary medicine and eye care. The growing meat consumption and the burgeoning pet industry further fuel market growth, as animal parts are integral to chondroitin sulfate production. Osteoarthritis, a common ailment among the elderly, notably in developed countries, presents a significant market opportunity, with chondroitin sulfate offering relief from inflammation and improving mobility, indicating a robust outlook for this segment.

Top-down and bottom-up approaches were used to estimate and validate the size of the Chondroitin Sulfate market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Chondroitin Sulfate Market Segments Analysis

Global Chondroitin Sulfate Market is segmented by Source, Form, Application and region. Based on Source, the market is segmented into Bovine, Swine, Poultry, Shark and Others. Based on Form, the market is segmented into Powder, Tablet and Others. Based on Application, the market is segmented into Pharmaceuticals andNutraceuticals, Animal Feed, Personal Care and Cosmetics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Chondroitin Sulfate Market

The increasing global population, particularly the aging demographic, is a key factor driving the growth of the chondroitin sulfate market. With older individuals more prone to joint-related disorders, such as osteoarthritis, the demand for effective treatments has risen. Chondroitin sulfate is widely recognized for its ability to alleviate pain, reduce inflammation, and enhance joint functionality, making it a preferred choice among healthcare providers and patients alike. This surge in age-related joint conditions has led to a heightened focus on therapies like chondroitin sulfate, thereby propelling its market and ensuring its significance in managing osteoarthritis and improving the quality of life for many.

Restraints in the Chondroitin Sulfate Market

The chondroitin sulfate market faces certain constraints due to the diverse regulatory standards and requirements established by various countries. Navigating these regulations can be intricate and labor-intensive, which poses significant challenges for new entrants aiming to establish themselves in the market. This complexity not only acts as a barrier to entry for potential competitors but also negatively influences overall market growth. As companies strive to meet these compliance demands, the process can consume valuable resources, ultimately hindering innovation and expansion within the chondroitin sulfate sector. Thus, regulatory challenges remain a critical restraint for the market's progress.

Market Trends of the Chondroitin Sulfate Market

The chondroitin sulfate market is witnessing a robust trend driven by the rising consumer inclination towards natural and organic ingredients in health supplements and nutraceuticals. As health-conscious consumers seek products with fewer artificial additives, the demand for chondroitin sulfate sourced from natural origins-such as bovine, porcine, and marine sources-has surged. This shift has prompted manufacturers to prioritize the development of high-quality chondroitin sulfate formulations that align with these preferences, leading to a proliferation of products marketed as organic or sustainably sourced. Consequently, this trend is expected to propel market growth, enhancing opportunities for innovation and diversification within the chondroitin sulfate segment.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis
• Patent Analysis

Global Chondroitin Sulfate Market Size by Source & CAGR (2025-2032)

• Market Overview
• Bovine
• Swine
• Poultry
• Shark
• Others

Global Chondroitin Sulfate Market Size by Form & CAGR (2025-2032)

• Market Overview
• Powder
• Tablet
• Others

Global Chondroitin Sulfate Market Size by Application & CAGR (2025-2032)

• Market Overview
• Pharmaceuticals and Nutraceuticals
• Animal Feed
• Personal Care and Cosmetics
• Others

Global Chondroitin Sulfate Market Size & CAGR (2025-2032)

• North America (Source, Form, Application)
  • US
  • Canada
• Europe (Source, Form, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Source, Form, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Source, Form, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Source, Form, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• TSI Group Co., LTD (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qingdao Wan Toulmin Biological Sources Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hebei Sanxin Industry Group Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioiberica S.A.U. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sigma-Aldrich, Inc. (Merck KGaA, Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZPD A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sino Siam Biotechnique Company Ltd. (Thailand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BRF S.A. (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-gen Extracts Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seikagaku Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Yantai Dongcheng Pharmaceutical Group Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shandong Haiyu Biological Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiaxing Hengjie Biopharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lianyungang Zhonghai Biological Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Yantai Ruikangda Biochemical Products Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shandong Topscience Biotech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Titan Biotech Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fido Pharma Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Velnex Medicare (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TSI Group Ltd. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations